VRDN
USDViridian Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$22.720
High
$23.050
Low
$22.140
Volume
4.98M
Company Fundamentals
Market Cap
2.1B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.03M
Exchange
NCM
Currency
USD
52-Week Range
Related News
BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target
BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.
Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease
- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports
Related Stocks
SLMBP
SLM Corporation Floating Rate Non-Cumulative Preferred Stock Series B
TBI
TrueBlue Inc.
KAR
OPENLANE Inc.
IH
iHuman Inc. American depositary shares each representing five ordinary shares
MRO
Marathon Oil Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.